Related Experiment Video
Updated: Oct 16, 2025
10:02
A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
Published on: November 3, 2016
24.7K
Neurologic and developmental considerations in children with medical complexity
Winona D Chua1, Mary Pipan2, Alyssa R Rosen1
1Perelman School of Medicine, University of Pennsylvania, United States.
Current Problems in Pediatric and Adolescent Health Care
|October 18, 2021
Summary
Children with medical complexity face higher risks for neurodevelopmental conditions. Pediatricians should monitor for these conditions and address behavioral changes by considering medical and mental health factors for comprehensive management.
Area of Science:
- Pediatric Medicine
- Neurodevelopmental Disorders
- Child Psychology
Background:
- Children with medical complexity have a higher incidence of neurodevelopmental conditions.
- Medical illness or hospitalization can exacerbate signs of neurodevelopmental issues in children.
- Early identification is crucial for timely intervention and support.
Purpose of the Study:
- To emphasize the importance of vigilance for neurodevelopmental conditions in children with medical complexity.
- To guide pediatricians in diagnosing and managing behavioral changes in this population.
- To highlight a multidisciplinary approach to care.
Main Methods:
- Review of existing literature on neurodevelopmental conditions in medically complex children.
- Clinical guidance for pediatricians in primary care, subspecialty, and hospital settings.
- Emphasis on differential diagnosis considering medical and mental health comorbidities.
Main Results:
- Neurodevelopmental conditions are a significant concern for children with medical complexity.
- Behavioral changes or regression in these children warrant thorough medical and mental health evaluation.
- Integrated management strategies are effective.
Conclusions:
- Pediatricians must proactively screen for neurodevelopmental conditions in medically complex children from infancy to adolescence.
- A comprehensive approach, including medical/mental health management, behavioral interventions, and skill-building, is essential for addressing maladaptive behaviors.
- Early and consistent monitoring improves outcomes for children with medical complexity.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
28
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
28
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
34
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
34
01:21Factors Affecting Drug Response: Overview
2.5K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.5K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
33
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
33
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
34
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
34
01:29Drug Dosing: Infants and Children
41
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
41